HNF6 is a host factor that restricts HBV replication via transcriptional and post-transcriptional mechanisms, suggesting that it is a potential therapeutic target in HBV-associated hepatitis-induced liver injury. The gene discussed is ONECUT1; the disease is hepatitis A virus infection.